Skip to main content
. 2021 Feb 19;75(4):255–262. doi: 10.1136/jclinpath-2020-207157

Figure 3.

Figure 3

Prognostic performance of core and extended laboratory markers. Balanced accuracy (A), weighted F1 score (B), AUC score (C) and ROC curves (D) for models with sequential inclusion of extended biomarkers for prediction of 28-day mortality. AUC, area under the curve; LDH, lactate dehydrogenase; PCT, procalcitonin; ROC, receiver operating characteristic.